Literature DB >> 25150444

Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line.

Naoki Ogura1, Koichi Watashi2, Toru Noguchi3, Takaji Wakita4.   

Abstract

Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) plays a central role in chronic HBV infection. However, analysis of the molecular mechanism of cccDNA formation is difficult because of the low efficiency in tissue cultured cells. In this study, we developed a more efficient cccDNA expression cell, Hep38.7-Tet, by subcloning from a tetracycline inducible HBV expression cell, HepAD38. Higher levels of cccDNA were produced in Hep38.7-Tet cells compared to HepAD38 cells. In Hep38.7-Tet cells, the cccDNA was detectable at six days after HBV induction. HBV e antigen (HBeAg) secretion was dependent upon cccDNA production. We screened chemical compounds using Hep38.7-Tet cells and HBeAg secretion as a marker. Most of the hit compounds have already been reported as anti-HBV compounds. These data suggested that Hep38.7-Tet cells will be powerful tools for analysis of the molecular mechanism of cccDNA formation/maintenance and development of novel therapeutic agents to control HBV infection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiviral; HBV; cccDNA

Mesh:

Substances:

Year:  2014        PMID: 25150444     DOI: 10.1016/j.bbrc.2014.08.029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  38 in total

1.  Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay.

Authors:  Shogo Nakajima; Koichi Watashi; Kento Fukano; Senko Tsukuda; Kousho Wakae; Hideki Aizaki; Masamichi Muramatsu; Takaji Wakita; Tetsuya Toyoda
Journal:  J Gastroenterol       Date:  2019-11-25       Impact factor: 7.527

2.  Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA.

Authors:  Lin Deng; Xiang Gan; Masahiko Ito; Ming Chen; Hussein H Aly; Chieko Matsui; Takayuki Abe; Koichi Watashi; Takaji Wakita; Tetsuro Suzuki; Toru Okamoto; Yoshiharu Matsuura; Masashi Mizokami; Ikuo Shoji; Hak Hotta
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

3.  A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.

Authors:  Manabu Kaneko; Koichi Watashi; Shinji Kamisuki; Hiroki Matsunaga; Masashi Iwamoto; Fumihiro Kawai; Hirofumi Ohashi; Senko Tsukuda; Satomi Shimura; Ryosuke Suzuki; Hideki Aizaki; Masaya Sugiyama; Sam-Yong Park; Takayoshi Ito; Naoko Ohtani; Fumio Sugawara; Yasuhito Tanaka; Masashi Mizokami; Camille Sureau; Takaji Wakita
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

4.  A Single Adaptive Mutation in Sodium Taurocholate Cotransporting Polypeptide Induced by Hepadnaviruses Determines Virus Species Specificity.

Authors:  Junko S Takeuchi; Kento Fukano; Masashi Iwamoto; Senko Tsukuda; Ryosuke Suzuki; Hideki Aizaki; Masamichi Muramatsu; Takaji Wakita; Camille Sureau; Koichi Watashi
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

5.  NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.

Authors:  Kento Fukano; Mizuki Oshima; Senko Tsukuda; Hideki Aizaki; Mio Ohki; Sam-Yong Park; Takaji Wakita; Kousho Wakae; Koichi Watashi; Masamichi Muramatsu
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

6.  Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action.

Authors:  Masaaki Toyama; Koichi Watashi; Masanori Ikeda; Atsuya Yamashita; Mika Okamoto; Kohji Moriishi; Masamichi Muramatsu; Takaji Wakita; Ashoke Sharon; Masanori Baba
Journal:  Antimicrob Agents Chemother       Date:  2022-05-23       Impact factor: 5.938

7.  Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis.

Authors:  Takeshi Suzuki; Yoshitaka Sato; Yusuke Okuno; Fumi Goshima; Tadahisa Mikami; Miki Umeda; Takayuki Murata; Takahiro Watanabe; Koichi Watashi; Takaji Wakita; Hiroshi Kitagawa; Hiroshi Kimura
Journal:  Commun Biol       Date:  2022-07-19

8.  Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx.

Authors:  Takahisa Kouwaki; Toru Okamoto; Ayano Ito; Yukari Sugiyama; Kazuo Yamashita; Tatsuya Suzuki; Shinji Kusakabe; Junki Hirano; Takasuke Fukuhara; Atsuya Yamashita; Kazunobu Saito; Daisuke Okuzaki; Koichi Watashi; Masaya Sugiyama; Sachiyo Yoshio; Daron M Standley; Tatsuya Kanto; Masashi Mizokami; Kohji Moriishi; Yoshiharu Matsuura
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

9.  RNA Exosome Complex Regulates Stability of the Hepatitis B Virus X-mRNA Transcript in a Non-stop-mediated (NSD) RNA Quality Control Mechanism.

Authors:  Hussein H Aly; Junya Suzuki; Koichi Watashi; Kazuaki Chayama; Shin-Ichi Hoshino; Makoto Hijikata; Takanobu Kato; Takaji Wakita
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

10.  Extracellular vesicles secreted by HBV-infected cells modulate HBV persistence in hydrodynamic HBV transfection mouse model.

Authors:  Masatoshi Kakizaki; Yuichiro Yamamoto; Motoyuki Otsuka; Kouichi Kitamura; Masatoshi Ito; Hideki Derek Kawai; Masamichi Muramatsu; Tatehiro Kagawa; Ai Kotani
Journal:  J Biol Chem       Date:  2020-07-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.